Literature DB >> 21976046

The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.

Hagit Cohen1, Tianmin Liu, Nitsan Kozlovsky, Zeev Kaplan, Joseph Zohar, Aleksander A Mathé.   

Abstract

Converging evidence implicates the regulatory neuropeptide Y (NPY) in anxiety- and depression-related behaviors. The present study sought to assess whether there is an association between the magnitude of behavioral responses to stress and patterns of NPY in selected brain areas, and subsequently, whether pharmacological manipulations of NPY levels affect behavior in an animal model of PTSD. Animals were exposed to predator-scent stress for 15 min. Behaviors were assessed with the elevated plus maze and acoustic startle response tests 7 days later. Preset cutoff criteria classified exposed animals according to their individual behavioral responses. NPY protein levels were assessed in specific brain regions 8 days after the exposure. The behavioral effects of NPY agonist, NPY-Y1-receptor antagonist, or placebo administered centrally 1 h post-exposure were evaluated in the same manner. Immunohistochemical technique was used to detect the expression of the NPY, NPY-Y1 receptor, brain-derived neurotrophic factor, and GR 1 day after the behavioral tests. Animals whose behavior was extremely disrupted (EBR) selectively displayed significant downregulation of NPY in the hippocampus, periaqueductal gray, and amygdala, compared with animals whose behavior was minimally (MBR) or partially (PBR) disrupted, and with unexposed controls. One-hour post-exposure treatment with NPY significantly reduced prevalence rates of EBR and reduced trauma-cue freezing responses, compared with vehicle controls. The distinctive pattern of NPY downregulation that correlated with EBR as well as the resounding behavioral effects of pharmacological manipulation of NPY indicates an intimate association between NPY and behavioral responses to stress, and potentially between molecular and psychopathological processes, which underlie the observed changes in behavior. The protective qualities attributed to NPY are supported by the extreme reduction of its expression in animals severely affected by the stressor and imply a role in promoting resilience and/or recovery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976046      PMCID: PMC3242318          DOI: 10.1038/npp.2011.230

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  78 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Anxiolytic activity of NPY receptor agonists in the conflict test.

Authors:  K T Britton; S Southerland; E Van Uden; D Kirby; J Rivier; G Koob
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

3.  Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.

Authors:  K T Britton; Y Akwa; M G Spina; G F Koob
Journal:  Peptides       Date:  2000-01       Impact factor: 3.750

Review 4.  BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis.

Authors:  Clive R Bramham; Elhoucine Messaoudi
Journal:  Prog Neurobiol       Date:  2005-06       Impact factor: 11.685

5.  Neuropeptide expression in rats exposed to chronic mild stresses.

Authors:  Valeriy Sergeyev; Serguei Fetissov; Aleksander A Mathé; Patricia A Jimenez; Tamas Bartfai; Patrick Mortas; Laurent Gaudet; Jean-Luc Moreau; Tomas Hökfelt
Journal:  Psychopharmacology (Berl)       Date:  2004-10-30       Impact factor: 4.530

6.  Long-lasting behavioral effects of juvenile trauma in an animal model of PTSD associated with a failure of the autonomic nervous system to recover.

Authors:  Hagit Cohen; Zeev Kaplan; Michael A Matar; Uri Loewenthal; Joseph Zohar; Gal Richter-Levin
Journal:  Eur Neuropsychopharmacol       Date:  2006-12-28       Impact factor: 4.600

7.  The relevance of differential response to trauma in an animal model of posttraumatic stress disorder.

Authors:  Hagit Cohen; Joseph Zohar; Michael Matar
Journal:  Biol Psychiatry       Date:  2003-03-15       Impact factor: 13.382

8.  Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder.

Authors:  Renu Sah; Nosakhare N Ekhator; Jeffrey R Strawn; Floyd R Sallee; Dewleen G Baker; Paul S Horn; Thomas D Geracioti
Journal:  Biol Psychiatry       Date:  2009-07-03       Impact factor: 13.382

9.  Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression.

Authors:  Katharina Domschke; Udo Dannlowski; Christa Hohoff; Patricia Ohrmann; Jochen Bauer; Harald Kugel; Peter Zwanzger; Walter Heindel; Jürgen Deckert; Volker Arolt; Thomas Suslow; Bernhard T Baune
Journal:  Eur Neuropsychopharmacol       Date:  2009-10-24       Impact factor: 4.600

10.  Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.

Authors:  Sameer N Goyal; Manoj A Upadhya; Dadasaheb M Kokare; Snehal M Bhisikar; Nishikant K Subhedar
Journal:  Brain Res       Date:  2009-02-27       Impact factor: 3.252

View more
  90 in total

1.  Expanding our understanding of neurobiological mechanisms of resilience by using animal models.

Authors:  Israel Liberzon; Dayan Knox
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

2.  Hippocampal Y2 receptor-mediated mossy fiber plasticity is implicated in nicotine abstinence-related social anxiety-like behavior in an outbred rat model of the novelty-seeking phenotype.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Pharmacol Biochem Behav       Date:  2014-08-23       Impact factor: 3.533

3.  A predator-based psychosocial stress animal model of PTSD in females: Influence of estrous phase and ovarian hormones.

Authors:  Phillip R Zoladz; Paul A D'Alessio; Sarah L Seeley; Charis D Kasler; Cassandra S Goodman; Kasey E Mucher; Alanis S Allison; Ian F Smith; Jordan L Dodson; Thorne S Stoops; Boyd R Rorabaugh
Journal:  Horm Behav       Date:  2019-08-21       Impact factor: 3.587

4.  Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.

Authors:  Katelynn M Corder; Qin Li; Mariana A Cortes; Aundrea F Bartley; Taylor R Davis; Lynn E Dobrunz
Journal:  Neuropeptides       Date:  2019-11-07       Impact factor: 3.286

5.  Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats.

Authors:  Fábio Teixeira Kuhn; Verônica Tironi Dias; Karine Roversi; Luciana Taschetto Vey; Daniele Leão de Freitas; Camila Simonetti Pase; Katiane Roversi; Juliana Cristina Veit; Tatiana Emanuelli; Marilise Escobar Bürger
Journal:  Neurotox Res       Date:  2015-07-19       Impact factor: 3.911

Review 6.  Neuropeptide Y and posttraumatic stress disorder.

Authors:  R Sah; T D Geracioti
Journal:  Mol Psychiatry       Date:  2012-07-17       Impact factor: 15.992

7.  Gastrodin reversed the traumatic stress-induced depressed-like symptoms in rats.

Authors:  Bombi Lee; Bongjun Sur; Mijung Yeom; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  J Nat Med       Date:  2016-07-14       Impact factor: 2.343

Review 8.  The predator odor avoidance model of post-traumatic stress disorder in rats.

Authors:  Lucas Albrechet-Souza; Nicholas W Gilpin
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

9.  Ginsenoside Rb1 rescues anxiety-like responses in a rat model of post-traumatic stress disorder.

Authors:  Bombi Lee; Bongjun Sur; Seong-Guk Cho; Mijung Yeom; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  J Nat Med       Date:  2015-11-26       Impact factor: 2.343

10.  Predictable chronic mild stress in adolescence increases resilience in adulthood.

Authors:  Lin Suo; Liyan Zhao; Jijian Si; Jianfeng Liu; Weili Zhu; Baisheng Chai; Yan Zhang; Jiajia Feng; Zengbo Ding; Yixiao Luo; Haishui Shi; Jie Shi; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2013-03-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.